Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21,746 | 6,743 | 9,182 | 7,838 | 10,862 |
| Receivables | 841 | 814 | 665 | 658 | 587 |
| Inventories | 371 | 375 | 367 | 1,203 | 582 |
| TOTAL | $23,316 | $9,055 | $11,047 | $10,910 | $12,793 |
| Non-Current Assets | |||||
| PPE Net | 25 | 25 | 31 | 35 | 42 |
| Intangibles | 8,434 | 8,086 | 7,917 | 8,090 | 7,893 |
| Other Non-Current Assets | 496 | 503 | 646 | 946 | 774 |
| TOTAL | $8,955 | $8,614 | $8,594 | $9,071 | $8,709 |
| Total Assets | $32,271 | $17,669 | $19,641 | $19,981 | $21,502 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 936 | 1,697 | 1,656 | 2,148 | 2,279 |
| Other current liabilities | 117 | 119 | 97 | 424 | 891 |
| TOTAL | $1,797 | $2,531 | $3,191 | $5,659 | $5,468 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 619 | 596 | 585 | 991 | 74 |
| Other Non-Current Liabilities | 15,198 | 14,059 | 14,597 | 16,600 | 18,024 |
| TOTAL | $15,326 | $14,207 | $14,763 | $16,785 | $18,227 |
| Total Liabilities | $17,123 | $16,738 | $17,954 | $22,444 | $23,695 |
| Shareholders' Equity | |||||
| Common Shares | 235,008 | 226,724 | 226,413 | 224,528 | 224,531 |
| Retained earnings | -321,363 | -319,592 | -314,724 | -316,891 | -316,844 |
| Other shareholders' equity | 101,503 | 93,799 | 89,998 | 89,900 | 90,120 |
| TOTAL | $15,148 | $931 | $1,687 | $-2,463 | $-2,193 |
| Total Liabilities And Equity | $32,271 | $17,669 | $19,641 | $19,981 | $21,502 |